Live Breaking News & Updates on Moderate Severe Hemophiliab Treated

Stay updated with breaking news from Moderate severe hemophiliab treated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

uniQure Inc.: uniQure to Participate in Multiple Upcoming Industry Conferences in June


uniQure Inc.: uniQure to Participate in Multiple Upcoming Industry Conferences in June
~ uniQure to host virtual Research & Development Day on June 22, 2021 ~
LEXINGTON, Mass. and AMSTERDAM, June 02, 2021(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming virtual investor and scientific conferences:
Jefferies Virtual Healthcare Conference, June 1 - 4, 2021
Members of uniQure s management team will participate in virtual one-on-one investor meetings throughout the day on Wednesday, June 2.
A fireside chat with Matt Kapusta (http://uniqure.com/about/management-team-matt-kapusta.php), chief executive officer, will take place the same day from 8:30 to 8:55 a.m. ET. The live webcast of the fireside chat can be accessed through the link displayed in the Investors & Newsroom (http://uniqure.com/investors-newsroom/events-presentations.php) s ....

Noord Holland , Chiara Russo , Ricardo Dolmetsch , Mariae Cantor , Matt Kapusta , Tom Malone , Etranacogene Dezaparvovec , Research Development Day On , Qure Virtual Research Development Day , European Hematology Association , Goldman Sachs , Raymond James Virtual Human Health Innovation Conference , Development Day , Virtual Healthcare Conference , Hematology Association , Moderate Severe Hemophiliab Treated , Patients With , Without Pre Existing Neutralizing Antibodies , Month Data , Annual Global Healthcare Conference , Virtual Research , James Virtual Human Health Innovation Conference , Qure Contacts , நூற்த் ஹாலண்ட் , சியாரா ருஸ்ஸோ , டோம் மலோந் ,